Systemic Corticosteroids Required Only for Moderate-to-Severe Ipilimumab-Induced Hepatitis

被引：0
|
作者：
De Felice, Kara M.
Markovic, Svetomir
Kottschade, Lisa A.
Finnes, Heidi D.
Kamath, Patrick S.
Raffals, Laura H.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1312
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
    Roekevisch, Evelien
    Spuls, Phyllis Ira
    Kuester, Denise
    Limpens, Jacqueline
    Schmitt, Jochen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : 429 - 438
  • [42] Comments on 'French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults'
    Schuster, C.
    Perrin, E.
    Riedl, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (09) : E310 - E310
  • [43] Impact of the French guidelines on the prescribing habits of systemic treatments for moderate-to-severe psoriasis
    Villani, A. P.
    Amatore, F.
    Tauber, M.
    Guillot, B.
    Viguier, M.
    Beylot-Barry, M.
    Jullien, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (11) : E747 - E748
  • [44] The economic impact of patients with moderate-to-severe atopic dermatitis eligible for systemic treatment
    Ariens, L. F. M.
    Van der Schaft, J.
    Os-Medendorp, H.
    De Bruin-Weller, M. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E38 - E38
  • [45] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L.
    Hahn, N.
    Nickoloff, B.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R.
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [46] 676-Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis
    Irvine, Alan D.
    Paller, Amy S.
    Hamon, Sara
    Horowitz, Julie
    Farrell, Annamaria
    Hatsell, Sarah
    Ehmann, Peter
    Rodriguez Marco, Ainara
    Bansal, Ashish
    Chen, Zhen
    Levy, Stephane
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [47] Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
    Subudhi, Sumit K.
    Aparicio, Ana
    Gao, Jianjun
    Zurita, Amado J.
    Araujo, John C.
    Logothetis, Christopher J.
    Tahir, Salahaldin A.
    Korivi, Brinda R.
    Slack, Rebecca S.
    Vence, Luis
    Emerson, Ryan O.
    Yusko, Erik
    Vignali, Marissa
    Robins, Harlan S.
    Sun, Jingjing
    Allison, James P.
    Sharma, Padmanee
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (42) : 11919 - 11924
  • [48] Induced hypernatremia in patients with moderate-to-severe ARDS: a randomized controlled study
    Bihari, Shailesh
    Prakash, Shivesh
    Dixon, Dani L.
    Cavallaro, Elena
    Bersten, Andrew D.
    INTENSIVE CARE MEDICINE EXPERIMENTAL, 2021, 9 (01)
  • [49] Induced hypernatremia in patients with moderate-to-severe ARDS: a randomized controlled study
    Shailesh Bihari
    Shivesh Prakash
    Dani L. Dixon
    Elena Cavallaro
    Andrew D. Bersten
    Intensive Care Medicine Experimental, 9
  • [50] Effect of Traditional Chinese Medicine (TCM) in moderate-to-severe eczema in clinic and animal model: beyond corticosteroids
    Srivastava, Kamal
    Yang, Nan
    Uzun, Serife
    Thanik, Erin
    Ehrlich, Paul
    Chung, Danna
    Yuan, Qian
    Nowak-Wegrzyn, Anna
    Li, Xiu-Min
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB198 - AB198
12345